Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
US6121276A · kind A · utility
23Cited by
18References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 1998 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | Jun 22, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Psychogenic impotence can be ameliorated without substantial undesirable side effects by administration of apomorphine and an antiemetic agent in an amount sufficient to substantially reduce nausea symptoms associated with the use of apomorphine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.